RxDoctor Payments Data

Matthew Kelly

Pediatric Infectious Diseases · Little Rock, ARNPI 1306004577

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $84,080 of the $84,725 with a category attached, or 99.2%. Every reported general payment came from a single manufacturer, Merck.

$84,725in general payments, 2019–2025

Across 27 payments — averaging $3137.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$85K
$946,934in research payments, 2019–2025

Across 47 payments — averaging $20,148 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$947K

What the payments were for

  • Consulting fees$84,08099%
  • Travel & lodging$4200%
  • Food & beverage$2250%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck27$84,725

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric infectious diseases providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Other pediatric infectious diseases in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →